Nurix Therapeutics (NRIX) Change in Taxes (2020 - 2021)

Nurix Therapeutics (NRIX) reported Change in Taxes of -$2.9 million for Q3 2021, up 81.33% year-over-year from -$1.6 million in Q3 2020, and down 250.18% quarter-over-quarter from -$839000.0 in Q2 2021.

Nurix Therapeutics (NRIX) Change in Taxes (2020 - 2021) Analysis & Trends

Nurix Therapeutics (NRIX) has 2 years of Change in Taxes data on file, last reported at -$2.9 million in Q3 2021.

  • Change in Taxes for Q3 2021 came in at -$2.9 million, up 81.33% year-over-year; the trailing twelve-month figure through Nov 2021 was -$3.6 million (changed N/A YoY), and the FY2021 annual result was -$3.6 million, down 194.7% from the prior year.
  • Change in Taxes fell to -$2.9 million in Q3 2021 per NRIX's latest filing, from -$839000.0 in the prior quarter.
  • Over five years, Change in Taxes peaked at $135000.0 in Q1 2021 and troughed at -$15.7 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Nurix Therapeutics 1.93 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Aug 31, 2021 -2.94 Mn
Aug 31, 2021 -2.94 Mn
May 31, 2021 -839,000.00
May 31, 2021 -839,000.00
Feb 28, 2021 135,000.00
Feb 28, 2021 135,000.00
Nov 30, 2020 -10,000.00
Nov 30, 2020 -10,000.00
Aug 31, 2020 -15.73 Mn
Aug 31, 2020 -15.73 Mn